Owlet
Public infant-monitoring company spanning consumer smart socks, subscription software, and prescription home pulse oximetry.
Lehi, UT
2012
101-250
$168M+
Self-Pay, Commercial Insurance, Medicaid
What They Do
Owlet sells connected infant monitoring hardware and software spanning its consumer Dream Sock line, subscription services such as Owlet360, and the prescription BabySat pulse oximetry product. The business started as a direct-to-consumer infant monitor company, then moved back toward the clinical market after FDA clearance for BabySat and Dream Sock. Revenue still appears primarily consumer and cash-pay, but the PromptCare channel adds reimbursed DME distribution for medically indicated monitoring. More than 2.5 million parents have used Owlet products, giving the company a large proprietary infant sleep and vitals dataset that now underpins its software and AI strategy.
Competitive Position
Owlet sits between consumer nursery-tech companies such as Nanit and Hatch and clinical infant-monitoring vendors serving NICU discharge and home pulse-ox workflows. Its clearest edge is owning both a recognizable consumer brand and FDA-cleared monitoring products, which gives it a larger longitudinal dataset than most hardware peers. The strategic question is whether that blend can produce a durable software and reimbursement business rather than remaining primarily a premium baby-device company.